Contemporary Management of Acute Lymphoblastic Leukemia

Author:

Language: English
Cover of the book Contemporary Management of Acute Lymphoblastic Leukemia

Subject for Contemporary Management of Acute Lymphoblastic Leukemia

Approximative price 205.02 €

In Print (Delivery period: 14 days).

Add to cartAdd to cart
Publication date:
350 p. · 16.5x22.8 cm · Hardback

Acute lymphocytic leukaemia (ALL) is a fast-growing cancer of a type of white blood cells called lymphocytes. These cells are found in the bone marrow and other parts of the body (MedlinePlus).

This book is a comprehensive guide to the management of Acute Lymphoblastic Leukaemia. Beginning with an introduction to the disease, its history and epidemiology, the next sections discuss diagnosis, classification, molecular pathogenesis, and cytogenetics.

The following chapters examine different treatment methods, with in depth discussion on chemotherapy and a chapter dedicated to stem cell transplantation.

Written by an experienced specialist from City of Hope National Medical Centre, California, this practical manual includes more than 50 images, illustrations and tables to enhance learning.

Key points

  • Comprehensive guide to management of Acute Lymphoblastic Leukaemia
  • In depth coverage of chemotherapy
  • Includes chapter on stem cell transplantation
  • Authored by experienced specialist from City of Hope National Medical Centre, California
  • Contributors
  • Foreword
  • Preface
  • Acknowledgments
  • Chapter 1: Treatment of Acute Lymphoblastic Leukemia: A Historical Perspective
  • Chapter 2: Epidemiology and Etiology of Acute Lymphoblastic Leukemia
  • Chapter 3: Diagnosis and Classification of Acute Lymphoblastic Leukemia
  • Chapter 4: Molecular Pathogenesis of Acute Lymphoblastic Leukemia
  • Chapter 5: Cytogenetics of Acute Lymphoblastic Leukemia
  • Chapter 6: Chemotherapy of Childhood Acute Lymphoblastic Leukemia
  • Chapter 7: Chemotherapy of Adult Acute Lymphoblastic Leukemia
  • Chapter 8: Use of Asparaginase in Acute Lymphoblastic Leukemia
  • Chapter 9: Monitoring of Minimal Residual Disease to Guide Therapy of Acute Lymphoblastic Leukemia
  • Chapter 10: Prophylaxis and Treatment of CNS Involvement in Acute Lymphoblastic Leukemia
  • Chapter 11: Pharmacogenomics of Acute Lymphoblastic Leukemia Chemotherapy
  • Chapter 12: Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia
  • Chapter 13: Late Effects of Acute Lymphoblastic Leukemia Therapy
  • Chapter 14: Novel Agents for the Treatment of Acute Lymphoblastic Leukemia

Vinod Pullarkat MD MRCP
Associate Professor, Department of Haematology and Haematopoietic Cell Transplantation, City of Hope National Medical Centre, California, USA